Cover Image

Prolonged hypereosinophilia associated with dupilumab for atopic dermatitis: A case series and review of literature

Saved in:

Bibliographic Details
Main Authors:	Gabriela Fonseca, BS (Author), Sivani Reddy, MD (Author), Tiffany Mayo, MD (Author)
Format:	Book
Published:	Elsevier, 2024-11-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Uveitis and hypereosinophilia associated with dupilumab in an atopic dermatitis patient
by: Shiyu Zhang, et al.
Published: (2023)

Tralokinumab as an Alternative to Dupilumab in a Patient with Atopic Dermatitis and Asthma who Developed Hypereosinophilia: A Case Report
by: Ilaria Trave, et al.
Published: (2024)

Onychodystrophy associated with dupilumab therapy for atopic dermatitis
by: Amanda E. Zubek, MD, PhD, et al.
Published: (2021)

A case report of uveitis secondary to dupilumab treatment for atopic dermatitis
by: Marissa Ayasse, BS, et al.
Published: (2021)

Alopecia areata after dupilumab for atopic dermatitis
by: Krystal Mitchell, MBA, et al.
Published: (2018)

JAK-inhibitors as rescue therapy in dupilumab-refractory severe atopic dermatitis: A case series of 6 patients
by: Neda Shahriari, MD, et al.
Published: (2023)

Dupilumab in patients with moderate to severe atopic dermatitis and multiple sclerosis
by: Maria Esposito, MD, et al.
Published: (2023)

Successful use of dupilumab in recalcitrant pediatric atopic dermatitis-like graft-versus-host disease: A case series
by: Lina Belmesk, MD, et al.
Published: (2024)

Alcohol-induced facial flushing in a patient with atopic dermatitis treated with dupilumab
by: Sean J. Igelman, BS, et al.
Published: (2020)

Dupilumab for the treatment of alopecia areata in children with atopic dermatitis
by: Sung Kyung Cho, BA, et al.
Published: (2021)

Drug-induced interstitial lung disease associated with dupilumab for the treatment of atopic dermatitis
by: Bethany F. Wilken, MSc, et al.
Published: (2024)

Remission of severe atopic dermatitis with dupilumab and rescue tofacitinib therapy
by: Danielle M. Peterson, MD, et al.
Published: (2021)

Experience with dupilumab in patients with atopic dermatitis
by: E. A. Glukhova, et al.
Published: (2023)

Dupilumab-induced phenotype switching from atopic dermatitis to psoriasis
by: Aakaash Varma, BA, et al.
Published: (2020)

Recalcitrant Palmar-Plantar Atopic Dermatitis Successfully Treated with Dupilumab: A Case Series
by: Deng L, et al.
Published: (2022)

Dupilumab Efficacy and Safety in Adolescents with Moderate-to-Severe Atopic Dermatitis: A Case Series
by: Adrien Mareschal, et al.
Published: (2020)

Severe hypereosinophilia in a patient treated with dupilumab and shift to mepolizumab: the importance of multidisciplinary management. A case report and literature review
by: Sara Munari, et al.
Published: (2024)

Dupilumab for the treatment of severe atopic dermatitis in a pregnant patient: A case report
by: Madeeha Mian, MD, et al.
Published: (2020)

Relapsing-remitting multiple sclerosis arising in a patient with atopic dermatitis on dupilumab
by: Leah Laageide, MD, et al.
Published: (2021)

Effects of dupilumab on hair in patients with atopic dermatitis - a review of the literature
by: Aleksandra Marczak, et al.
Published: (2022)

Atopic dermatitis: real-life experience with tralokinumab after dupilumab failure: a case series
by: Patrícia Amoedo, et al.
Published: (2024)

Efficacy of dupilumab in moderate and severe atopic dermatitis
by: Stephan Weidinger, et al.
Published: (2023)

Dupilumab in the Treatment of Cheilitis in Atopic Dermatitis Patients
by: Shan J, et al.
Published: (2022)

Conjunctivitis in patients with atopic dermatitis treated with dupilumab
by: Sandra Ferreira, et al.
Published: (2020)

Two‐sided influence of dupilumab on alopecia areata co‐existing with severe atopic dermatitis: A case series and literature review
by: Masahiro Fukuyama, et al.
Published: (2023)

A Literature Review of Real-World Effectiveness and Safety of Dupilumab for Atopic Dermatitis
by: Masahiro Kamata, et al.
Published: (2021)

Is Dupilumab a chance for patients with moderate to severe atopic dermatitis? Literature review
by: Paweł Iwańczuk
Published: (2024)

Dupilumab normalizes correlates of lysosomal function in atopic dermatitis
by: Christina Bürgler, et al.
Published: (2024)

Dupilumab in atopic dermatitis patients with chronic hepatitis B
by: Masako Matsutani, et al.
Published: (2022)

The application of the biological treatment in atopic dermatitis: focus on dupilumab
by: Yu. S. Smolkin, et al.
Published: (2023)

Atopic Dermatitis Treated Safely with Dupilumab during Pregnancy: A Case Report and Review of the Literature
by: Yolanka Lobo, et al.
Published: (2021)

COVID-19 in Patients with Atopic Dermatitis Treated with Dupilumab: Three Cases and a Literature Review
by: Ceryn J, et al.
Published: (2021)

Dupilumab-induced pityriasis rosea in a 28-year-old male with atopic dermatitis
by: Faraz Yousefian, DO, et al.
Published: (2024)

Treatment efficacy of dupilumab in a hyper-immunoglobulin E syndrome patient with severe atopic dermatitis
by: Chia-Jui Su, MD, et al.
Published: (2021)

Dupilumab Provides Rapid and Sustained Improvement in SCORing Atopic Dermatitis Outcomes in Paediatric Patients with Atopic Dermatitis
by: Andreas Wollenberg, et al.
Published: (2022)

Severe cutaneous reaction with initiation of dupilumab for atopic dermatitis and prurigo nodularis: An unusual adverse effect
by: Leore Lavin, MSc, et al.
Published: (2024)

Severe Multi-Organ Failure and Hypereosinophilia: When to Call It "Idiopathic"?
by: Massimo Radin MD, et al.
Published: (2018)

Successful Use of Dupilumab in the Treatment of Acquired Perforating Dermatosis Associated with Atopic Dermatitis
by: Niccolò Gori, et al.
Published: (2024)

Dupilumab improved atopic dermatitis without aggravating tuberculous eosinophilic pleural effusion in hyperimmunoglobulin-E syndrome
by: Piyaporn Chokevittaya, MD, et al.
Published: (2024)

Improvement of atopic dermatitis and alopecia universalis with dupilumab: a case report
by: Lama Alotaibi, et al.
Published: (2021)